82 related articles for article (PubMed ID: 28315329)
1. Atorvastatin prevents Angiotensin II induced myocardial hypertrophy in vitro via CCAAT/enhancer-binding protein β.
Chen Y; Yu S; Zhang N; Li Y; Chen S; Chang Y; Sun G; Sun Y
Biochem Biophys Res Commun; 2017 Apr; 486(2):423-430. PubMed ID: 28315329
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y
Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326
[TBL] [Abstract][Full Text] [Related]
3. Swainsonine induces apoptosis of rat cardiomyocytes via mitochondria‑mediated pathway.
Zheng X; Wang S; Chen D; Yang X
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):136-141. PubMed ID: 29729707
[TBL] [Abstract][Full Text] [Related]
4. Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism.
Sun D; Yang F
Biochem Biophys Res Commun; 2017 Apr; 486(2):329-335. PubMed ID: 28302481
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes.
Tie Y; Zhai C; Zhang Y; Qin X; Yu F; Li H; Shan M; Zhang C
J Cell Mol Med; 2018 Mar; 22(3):1475-1488. PubMed ID: 29266779
[TBL] [Abstract][Full Text] [Related]
6. C/EBPβ knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFκB.
Zou J; Li H; Chen X; Zeng S; Ye J; Zhou C; Liu M; Zhang L; Yu N; Gan X; Zhou H; Xian Z; Chen S; Liu P
Mol Cell Endocrinol; 2014 Jun; 390(1-2):18-25. PubMed ID: 24704266
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin Attenuates Myocardial Hypertrophy Induced by Chronic Intermittent Hypoxia In Vitro Partly through miR-31/PKCε Pathway.
Ren J; Liu W; Li GC; Jin M; You ZX; Liu HG; Hu Y
Curr Med Sci; 2018 Jun; 38(3):405-412. PubMed ID: 30074205
[TBL] [Abstract][Full Text] [Related]
8. Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway.
Yang Y; Du J; Xu R; Shen Y; Yang D; Li D; Hu H; Pei H; Yang Y
Aging (Albany NY); 2020 Nov; 13(1):493-515. PubMed ID: 33259334
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.
Ryall KA; Bezzerides VJ; Rosenzweig A; Saucerman JJ
J Mol Cell Cardiol; 2014 Jul; 72():74-84. PubMed ID: 24613264
[TBL] [Abstract][Full Text] [Related]
10. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts.
Ji L; Liu Y; Zhang Y; Chang W; Gong J; Wei S; Li X; Qin L
Can J Physiol Pharmacol; 2016 Sep; 94(9):996-1006. PubMed ID: 27376621
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of Low Ambient Temperature-Induced Myocardial Hypertrophy by Atorvastatin via Promoting Bcl-2 Expression.
Liang J; Yin K; Cao X; Han Z; Huang Q; Zhang L; Ma W; Ding F; Bi C; Feng D; Pan Z; Liu Y
Cell Physiol Biochem; 2017; 41(1):286-295. PubMed ID: 28214881
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch.
Cheng WP; Lo HM; Wang BW; Chua SK; Shyu KG
J Cell Mol Med; 2019 Feb; 23(2):1406-1414. PubMed ID: 30511410
[TBL] [Abstract][Full Text] [Related]
13. Decreased PGC1- α levels and increased apoptotic protein signaling are associated with the maladaptive cardiac hypertrophy in hyperthyroidism.
Teixeira RB; Barboza TE; DE Araujo CC; Siqueira R; DE Castro AL; Bonetto JHP; DE Lima-Seolin BG; Carraro CC; Bello-Klein A; Singal PK; Araujo ASDR
J Biosci; 2018 Dec; 43(5):887-895. PubMed ID: 30541949
[TBL] [Abstract][Full Text] [Related]
14. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin attenuates TNF-α-induced increase of glucose oxidation through PGC-1α upregulation in cardiomyocytes.
Gao F; Ni Y; Luo Z; Liang Y; Yan Z; Xu X; Liu D; Wang J; Zhu S; Zhu Z
J Cardiovasc Pharmacol; 2012 Jun; 59(6):500-6. PubMed ID: 22343369
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional coactivator PGC-1α contributes to decidualization by forming a histone-modifying complex with C/EBPβ and p300.
Takagi H; Tamura I; Fujimura T; Doi-Tanaka Y; Shirafuta Y; Mihara Y; Maekawa R; Taketani T; Sato S; Tamura H; Sugino N
J Biol Chem; 2022 May; 298(5):101874. PubMed ID: 35358514
[TBL] [Abstract][Full Text] [Related]
17. KLF5 overexpression attenuates cardiomyocyte inflammation induced by oxygen-glucose deprivation/reperfusion through the PPARγ/PGC-1α/TNF-α signaling pathway.
Li Y; Li J; Hou Z; Yu Y; Yu B
Biomed Pharmacother; 2016 Dec; 84():940-946. PubMed ID: 27764756
[TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid attenuates cardiac hypertrophy via inhibition of C/EBPβ activation.
Zou J; Gan X; Zhou H; Chen X; Guo Y; Chen J; Yang X; Lei J
Mol Cell Endocrinol; 2015 Jan; 399():321-9. PubMed ID: 25450863
[TBL] [Abstract][Full Text] [Related]
19. Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes.
Fabris B; Candido R; Bortoletto M; Zentilin L; Sandri M; Fior F; Toffoli B; Stebel M; Bardelli M; Belgrado D; Giacca M; Carretta R
J Hypertens; 2007 Jul; 25(7):1481-90. PubMed ID: 17563572
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin protects H9c2 cardiomyocytes from angiotensin II-induced apoptosis through the endoplasmic reticulum stress pathway.
Yang C; Wang Y; Liu H; Li N; Sun Y; Liu Z; Yang P
J Cardiovasc Pharmacol; 2012 May; 59(5):465-71. PubMed ID: 22269847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
